CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 28 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $284,000 | -61.7% | 145,000 | 0.0% | 0.02% | -64.8% |
Q3 2019 | $742,000 | -28.5% | 145,000 | 0.0% | 0.07% | -15.5% |
Q2 2019 | $1,038,000 | -56.6% | 145,000 | -19.4% | 0.08% | -57.1% |
Q1 2019 | $2,390,000 | +38.4% | 180,000 | -18.0% | 0.20% | +44.1% |
Q4 2018 | $1,727,000 | -47.7% | 219,495 | -26.4% | 0.14% | -43.8% |
Q3 2018 | $3,303,000 | -35.1% | 298,061 | -21.4% | 0.24% | -27.3% |
Q2 2018 | $5,086,000 | -3.1% | 379,000 | -6.2% | 0.33% | -11.9% |
Q1 2018 | $5,248,000 | +9.4% | 404,000 | -22.5% | 0.38% | +2.7% |
Q4 2017 | $4,795,000 | +13.3% | 521,247 | -0.7% | 0.37% | +22.3% |
Q3 2017 | $4,232,000 | +39.5% | 525,000 | -0.3% | 0.30% | +25.4% |
Q2 2017 | $3,034,000 | +34.0% | 526,665 | 0.0% | 0.24% | +12.7% |
Q1 2017 | $2,265,000 | +127.0% | 526,665 | -8.7% | 0.21% | +67.7% |
Q4 2016 | $998,000 | -17.9% | 576,665 | -8.0% | 0.13% | +13.4% |
Q3 2016 | $1,216,000 | +6.9% | 626,978 | -4.0% | 0.11% | -18.8% |
Q2 2016 | $1,137,000 | +18.7% | 653,216 | -7.9% | 0.14% | +6.2% |
Q1 2016 | $958,000 | -47.8% | 709,440 | -34.7% | 0.13% | -27.0% |
Q4 2015 | $1,835,000 | -13.9% | 1,085,681 | -1.1% | 0.18% | -4.3% |
Q3 2015 | $2,131,000 | +6.8% | 1,098,198 | +48.0% | 0.19% | +31.0% |
Q2 2015 | $1,996,000 | -78.0% | 742,126 | -43.4% | 0.14% | -80.4% |
Q1 2015 | $9,072,000 | -32.6% | 1,311,000 | -4.2% | 0.72% | -21.6% |
Q4 2014 | $13,453,000 | +57.3% | 1,368,557 | +9.5% | 0.92% | +56.3% |
Q3 2014 | $8,550,000 | – | 1,250,000 | – | 0.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |